Results 221 to 230 of about 68,966 (291)
ABSTRACT Background Pharmacotherapy offers a potential solution for individuals with overweight and obesity to decrease their body weight. However, there is limited knowledge of the effects of antiobesity agents on the distribution of body fat. Methods The PubMed, Embase, and Cochrane Library databases were reviewed for randomized controlled trials ...
Xiuqi Qiao +4 more
wiley +1 more source
Automated MRI-based brain volumetric analysis in women with polycystic ovary syndrome. [PDF]
Baspinar N, Salk S, Ersoz A.
europepmc +1 more source
Aging‐associated upregulation of NPY1R drives p‐CREB activation, triggering inflammation, mitochondrial dysfunction, and extracellular matrix imbalance to promote ovarian senescence. Pharmacological inhibition of NPY1R with BIBO 3304 restores ovarian homeostasis, highlighting a therapeutic strategy for reproductive aging. ABSTRACT Ovarian senescence is
Junnan Fang +15 more
wiley +1 more source
Prevalence of polycystic ovary syndrome among adolescents depending on the adopted diagnostic criteria. [PDF]
Jakubowska-Kowal K +3 more
europepmc +1 more source
We conducted integrative genomic analyses of large‐scale GWAS summary data to explore the shared polygenic architecture and causal link between female fat distribution (WHRadjBMI) and preeclampsia, identifying novel loci and critical vascular–immune pathways with implications for risk prediction.
Man Wang +5 more
wiley +1 more source
Polyendocrine metabolic ovarian syndrome (PMOS)/polycystic ovary syndrome (PCOS): current and future trends. [PDF]
Chan JL, Masini I, Pisarska MD.
europepmc +1 more source
A Nanoparticle‐Integrated Complete Manufacturing Pipeline of Chemically Engineered Exosomes
We report a novel manufacture technology of chemically engineered exosomes. The four steps of manufacturing, i.e., biogenesis, loading, isolation, and storage, are integrated by the use of a nanoparticle. The manufacture technology incorporates three innovative components, i.e., a new nano‐bio effect, a new composite nanoparticle, and a new isolation ...
Xiaowei Wen +13 more
wiley +1 more source
Outcome-specific shifts in homocysteine-androgen correlations in polycystic ovary syndrome. [PDF]
Han Q, Zhao J, Li M, Xin M, Yin X, He J.
europepmc +1 more source
Social deprivation, race, and metabolic syndrome in patients with polycystic ovary syndrome. [PDF]
Lee IT +6 more
europepmc +1 more source

